Showing results (781-790 of 1,011) with videos related to
Sort By:
Pageof 102
Infection and Immunity|December 6, 2021
Identifying Targets of Protective Antibodies against Severe Malaria in Papua, Indonesia, Using Locally Expressed Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1Janavi S Rambhatla, Gerry Q Tonkin-Hill, Eizo Takashima, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumorM Colleoni, S Li, R D Gelber, et al.Journal of the National Cancer Institute|November 2, 2006
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assaysMeredith M Regan, Giuseppe Viale, Mauro G Mastropasqua, et al.Communications Biology|June 22, 2023
Maturational networks of human fetal brain activity reveal emerging connectivity patterns prior to ex-utero exposureVyacheslav R Karolis, Sean P Fitzgibbon, Lucilio Cordero-Grande, et al.Malaria Journal|November 11, 2025
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in PakistanBushra Qurashi, Shan-E-Zehra Zaidi, Muhammad Mushtaque, et al.Plos Neglected Tropical Diseases|May 8, 2020
Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, IndonesiaZuleima Pava, Agatha M Puspitasari, Angela Rumaseb, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study GroupG Marini, S Murray, A Goldhirsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trialMarianne Ewertz, Kathryn P Gray, Meredith M Regan, et al.British Journal of Cancer|November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancerJ Bernhard, D Zahrieh, A S Coates, et al.Elife|December 6, 2022
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysisJames A Watson, Robert J Commons, Joel Tarning, et al.Pageof 102